LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Dose-Efficient X-Ray Imaging Method Produces Micrometer Resolution Images of Biopsy Samples

By LabMedica International staff writers
Posted on 20 Dec 2023
Image: Experimental setup of the dose-efficient X-ray imaging method (Photo courtesy of KIT)
Image: Experimental setup of the dose-efficient X-ray imaging method (Photo courtesy of KIT)

X-ray imaging plays a vital role in revealing the hidden structures and processes within living cells and organisms. However, the ionizing nature of X-ray radiation, composed of high-energy electromagnetic waves, poses a risk of damaging DNA, which in turn limits the duration of observation. Traditional X-ray imaging of soft tissues often results in low-contrast images, but phase contrast methods have been found to yield much clearer contrasts at lower radiation doses. However, achieving higher resolution in X-ray imaging is challenging due to the need for increased radiation dose, which is compounded by the reduced efficiency of high-resolution detectors, leading to further increase in radiation exposure. Until now, high-resolution X-ray phase contrast imaging of living biological samples could only be performed for a limited time before radiation caused significant damage.

At the Karlsruhe Institute of Technology (KIT, Karlsruhe, Germany), a team of researchers has innovated a technique that utilizes radiation more effectively and achieves micrometer-level resolution imaging. This method is suitable for observing both living organisms and delicate materials, opening new possibilities in fields like biology, biomedicine, and materials science. The novel system integrates X-ray phase contrast imaging with a Bragg magnifier and a photon-counting detector. In this setup, a photon-counting detector with 55-micrometer pixel size is used, and before capturing the specimen’s X-ray image, it is magnified using a Bragg magnifier. This magnification process allows the specimen's resolution to reach approximately 1 micrometer. The Bragg magnifier itself comprises two perfectly aligned silicon crystals, where the magnification effect is derived from asymmetric diffraction in the crystal lattice of silicon. A significant benefit of this Bragg magnifier is its exceptional optical image transmission, enabling almost complete replication of all spatial frequencies up to the resolution limit.

By combining propagation-based X-ray phase contrast with a Bragg magnifier and a photon-counting detector, all fine-tuned for 30 keV X-ray energy, the method achieves near-maximal dose efficiency for X-ray phase contrast imaging. This advancement permits extended observation periods of small living organisms with detailed micrometer resolution. The team showcased this technique in a preliminary study on tiny parasitic wasps, observing their activities inside host eggs and their emergence over more than 30 minutes. Future plans involve enhancing the setup to expand the field of view and boost mechanical stability, thereby enabling even longer measurement durations.

“Instead of converting the X-ray image into an image with visible light and enlarging it afterwards, we enlarge it directly,” said LAS doctoral researcher Rebecca Spiecker. “Thanks to this approach, we can use highly efficient large-area detectors. The method is also suited for biomedical applications, an example being the gentle three-dimensional histological investigation of biopsy samples.”

Related Links:
KIT

Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
Gold Member
Hematology Analyzer
Medonic M32B

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more